Recall Register

Drug recall: Revitaderm Wound Care Gel, Benzalkonium Chloride 0.1%, packaged in 1.0 FL OZ (37 mL) bottle, shorter twist cap…

Class I FDA enforcement event 98731. Recall start date: . Status in the FDA record: Ongoing.

Reason for recall, in the words of FDA

CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry

Class I, in the words of FDA

a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death

Blaine Labs Inc started this drug recall on 8 Apr 2026. The firm address in the FDA record is in Santa Fe Springs, CA. FDA put the recall in Class I. FDA event 98731 has 8 product records. The first FDA enforcement report date is 8 Jul 2026. The record gives the status Ongoing.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Nationwide in the USA

Recalling firm

Blaine Labs Inc, Santa Fe Springs, CA.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

8 product records in the event.

FDA event 98731: product records
Recall numberProductQuantityClassStatusReport date
D-0692-2026Revitaderm Wound Care Gel, Benzalkonium Chloride 0.1%, packaged in 1.0 FL OZ (37 mL) bottle, shorter twist cap, Manufactured By: Blaine Labs, Inc. 11037 Lockport Place Santa Fe Springs, CA 90670, NDC 63347-120-02.1,171 - 1 oz bottlesClass IOngoing8 Jul 2026
D-0693-2026TRIFLUENT PHARMA TRIDERGEL Wound Care Gel, (Benzalkonium Chloride 0.1%), 1.0 fl oz, (29.6 mL) bottle with long pointy cap, Manufactured for: Trifluent Pharma, LLC. San Antonio, TX 78213. NDC 73352-520-01.519 - 1 oz bottlesClass IIOngoing8 Jul 2026
D-0694-2026TRIPENICOL S Antifungal Solution (Undecylenic Acid 25%), 1.25 FL OZ (37.5 mL) bottle, Manufactured For: Trifluent Pharma, LLC, San Antonio, TX 78213, NDC 73352-550-01.144 bottlesClass IIOngoing8 Jul 2026
D-0695-2026TERPENICOL Antifungal Cream (Undecylenic Acid 13%), 1.0 oz (28 g) bottles, Manufactured By: Blaine Labs, Inc., 11037 Lockport Place, Sante Fe Springs, CA 90670, NDC 63347-601-01.22,143 bottlesClass IIOngoing8 Jul 2026
D-0696-2026vite20 Antifungal Cream, (10% Undecylenic Acid), 0.54 OZ (15 g) bottle, Manufactured By: Blaine Labs, Inc., 11037 Lockport Place, Sante Fe Springs, CA 90670, UPC 6 16728 00039 2.26,475 bottlesClass IIOngoing8 Jul 2026
D-0697-2026TERPENICOL Antifungal Solution, (Undecylenic (10-Undecenoic) acid 25%), 1.0 Fl Oz (29.6 mL), Manufactured By: Blaine Labs, Inc., 11037 Lockport Place, Santa Fe Springs, CA 90670. NDC 63347-600-015,801 bottlesClass IIOngoing8 Jul 2026
D-0698-2026Fungal Fusion ERADICATION Solution, Antifungal & Antimicrobial Kit. Contains, 1x2 oz bottle Fungal Fusion Antifungal (Miconazole Nitrate) Cream, 1x2oz bottle Fungal Fusion Antifungal Solution (25% Undecylenic Acid) and 1x1oz bottle of Fungal Fusion Eradication Antimicrobial Show Spray (isopropyl Alcohol, D-Limonene,…1,500 bottlesClass IIOngoing8 Jul 2026
D-0699-2026Revitaderm Wound Care, First Aid Antiseptic Gel, Benzalkonium Chloride 0.1%) packaged as (a) 1.0 Fl OZ (16 mL) bottle, long pointy cap, NDC 63347-120-02; (b) 3.0 Fl OZ (85 g) tube, with short twist cap, NDC 63347-120-01; Manufactured By: Blaine Labs, Inc. 11037 Lockport Place, Santa Fe Springs, CA 90670,5,555 bottles and tubesClass IIOngoing8 Jul 2026

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class I: The highest of the three FDA recall classes.

The event in context

Drug events that started in 2026
234
Share of these events in Class I
11%
Product records in this event
8Median of the firm: 8
Events of the firm on the register
2

Other events of the firm

Other FDA enforcement events of Blaine Labs Inc
InitiatedProduct (first record)TypeClassRecords
25 Jan 2022REVITADERM WOUND CARE GEL, (Benzalkonium Chloride in a gel containing transforming growth factor-b), 0.1%, packaged in 2 Event 89481DrugClass I1

Official channels

Cite this page

Recall Register. FDA enforcement event 98731. https://recallregister.com/fda/i/98731/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Nationwide in the USA
What quantity of product is in FDA event 98731?
The event has 8 product records. The first record gives this quantity: 1,171 - 1 oz bottles
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2026 have the same class?
11% of the 234 drug events that started in 2026 are in Class I.